Firivumab Biosimilar – Anti-hemagglutinin HA mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameFirivumab Biosimilar - Anti-hemagglutinin HA mAb - Research Grade
SourceCAS 1443004-15-6
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsFirivumab,CT-P22,hemagglutinin HA,anti-hemagglutinin HA
ReferencePX-TA1361
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Firivumab Biosimilar - Anti-hemagglutinin HA mAb - Research Grade

General information on Anti-Influenza A virus hemagglutinin HA[Influenza A virus] (Firivumab) Monoclonal Antibody

Firivumab has been investigated for the prevention and treatment of Influenza A infection.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Firivumab Biosimilar – Anti-hemagglutinin HA mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products